RMDFX Performance — Aspiriant Defensive Allocation Fund, N/a Class
Data updated: 2026-08-25
RMDFX returned +5.55% year to date and +16.52% over one year to Jun 2026. Annualised returns are +11.77% over 3 years and +6.25% over 5 years. The fund beat its Market Neutral category average: $100 invested three years ago grew to $140, against $139 for the category, and to $117 over one year, against $113. Volatility over the past three years was 4.76% a year. In the 12 months to Jun 2026 the fund lost a net $10.7M, and assets reached $1.08B.
RMDFX Growth of $100
What $100 invested in Aspiriant Defensive Allocation Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Market Neutral category average over the same months.
| Period | RMDFX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $117 | $113 |
| 3 years (Jul 2023 – Jun 2026) | $140 | $139 |
| 5 years (Jul 2021 – Jun 2026) | $135 | $143 |
| Since data start (Sep 2019 – Jun 2026) | $154 | $171 |
RMDFX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.55% |
| 1 year | +16.52% |
| 3 years (annualised) | +11.77% |
| 5 years (annualised) | +6.25% |
RMDFX Annual Returns
Calendar-year total returns of Aspiriant Defensive Allocation Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +5.55% |
| 2025 | +18.83% |
| 2024 | +6.20% |
| 2023 | +7.99% |
| 2022 | −6.83% |
| 2021 | +4.21% |
| 2020 | +5.09% |
| 2019 (Sep–Dec) | +4.88% |
RMDFX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.7% | +2.8% | −3.1% | +2.0% | +1.6% | −1.4% | — | — | — | — | — | — |
| 2025 | +2.2% | +0.8% | +0.9% | +0.8% | +1.0% | +1.6% | +0.4% | +2.4% | +2.4% | +1.5% | +1.7% | +1.6% |
| 2024 | +0.2% | +1.1% | +2.3% | 0.0% | +2.0% | −1.0% | +1.7% | −0.1% | +1.0% | −1.2% | −0.2% | +0.4% |
| 2023 | +2.2% | −0.9% | +0.5% | +0.9% | −1.6% | +1.9% | +1.7% | −0.6% | 0.0% | −0.4% | +1.9% | +2.1% |
| 2022 | −0.7% | −0.3% | −0.6% | −1.9% | +0.1% | −3.7% | +0.9% | −1.1% | −3.3% | +0.7% | +2.7% | +0.2% |
| 2021 | +0.1% | −0.3% | +0.7% | +1.8% | +2.4% | −1.5% | +0.1% | +0.4% | −1.3% | +0.8% | −1.2% | +2.3% |
| 2020 | −0.7% | −2.3% | −8.3% | +4.7% | +1.3% | +1.5% | +3.6% | +1.2% | −1.5% | −0.3% | +3.4% | +3.0% |
| 2019 | — | — | — | — | — | — | — | — | +1.0% | +1.0% | +0.7% | +2.1% |
RMDFX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 4.76%
- 3-year Sharpe ratio: 1.53 (vs 4.5% risk-free rate)
- Best month: +3.70% (Jan 2026)
- Worst month: −3.08% (Mar 2026)
RMDFX Fund Flows
Monthly money in and out of Aspiriant Defensive Allocation Fund, from SEC Form N-PORT.
- 12-month net flow: −$10.7M
- 12-month gross sales (incl. reinvestments): $140.8M
- Sales ÷ redemptions: 0.93×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $9.1M | $7.1M | $1.9M |
| May 2026 | $6.7M | $5.8M | $941K |
| Apr 2026 | $3.4M | $9.9M | −$6.5M |
| Mar 2026 | $12.1M | $9.7M | $2.4M |
| Feb 2026 | $8.1M | $4.5M | $3.6M |
| Jan 2026 | $27.8M | $5.9M | $21.9M |
| Dec 2025 | $51.2M | $52.2M | −$1.1M |
| Nov 2025 | $3.8M | $8.5M | −$4.6M |
| Oct 2025 | $6.6M | $17.1M | −$10.5M |
| Sep 2025 | $3.5M | $10.8M | −$7.3M |
| Aug 2025 | $3.3M | $10.4M | −$7.1M |
| Jul 2025 | $5.3M | $9.6M | −$4.3M |
RMDFX Assets Under Management
Net assets of Aspiriant Defensive Allocation Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $1.08B |
| 2026-03-31 | $1.06B |
| 2025-12-31 | $998.31M |
| 2025-09-30 | $1.01B |
| 2025-06-30 | $979.08M |
| 2025-03-31 | $970.99M |
| 2024-12-31 | $994.51M |
| 2024-09-30 | $1.12B |
| 2024-06-30 | $1.13B |
| 2024-03-31 | $1.25B |
| 2023-12-31 | $1.31B |
| 2023-09-30 | $1.34B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.